Navigation Links
Queen's scientists seek vaccine for Pseudomonas infection
Date:3/7/2012

Queen's University scientists working on a vaccine to combat Pseudomonas have received a major financial boost from Northern Ireland Chest Heart and Stroke (NICH&S).

The local charity has awarded Queen's Centre for Infection and Immunity a grant of 91,000 to help with their hunt for a vaccine.

Pseudomonas, which can be a killer in vulnerable adults and children, commonly infects the lungs of people suffering from cystic fibrosis (CF). CF damages a number of vital organs, particularly the lungs. It currently affects one in 2,500 newborn babies and Pseudomonas infection occurs in 80 per cent of adults living with CF. Currently in Northern Ireland CF affects 440 people in Northern Ireland, 190 of them children.

If a vaccine can be found, survival rates would increase for those affected by the serious genetic condition.

CF is caused by a genetic defect which results in thick, sticky mucous in the lungs, which becomes infected with bugs, in particular Pseudomonas. These bugs are almost impossible to eradicate, even with long-term antibiotics. This results in damage to the lungs, ultimately leading to early death through breathing difficulties.

Professor Stuart Elborn and Dr Rebecca Ingram, from Queen's Centre for Infection and Immunity are leading the study. Dr Ingram said: "Pseudomonas is around us all the time, and is normally cleared easily from our bodies, however, the mucus in the lungs of CF patients creates a perfect environment for the bacteria to live and multiply.

"In our study, patients' blood cells are placed on a special membrane and then mixed with different parts of the bacteria, to see if the body recognises them and so releases 'attack' molecules to deal with the infection. A dye is used to highlight the spots where this process is happening. It is the first time the technique has been used to examine human responses to Pseudomonas. Knowing which parts of the infection can most easily be recognised by the body will be a key piece in the jigsaw leading to the discovery of a vaccine."

The Chief Executive of NI Chest Heart & Stroke, Andrew Dougal, said: "Cystic fibrosis is a devastating illness primarily affecting the lungs. We are delighted to be supporting this high quality local research at Queen's, which brings hope of a Pseudomonas vaccine to improve survival rates. Often, these research grant awards are made possible only by the generosity of people who bequeath money to us in their wills. Legacies have become a vitally important source of income at a time of economic downturn".


'/>"/>

Contact: Lisa McElroy
lisa.mcelroy@qub.ac.uk
44-289-097-5384
Queen's University Belfast
Source:Eurekalert

Related biology news :

1. Protein love triangle key to crowning bees queens?
2. Clemson University and the University of Queensland form biofuels research partnership
3. Stanford scientists develop gene therapy approach to grow blood vessels in ischemic limbs
4. A*STAR scientists make groundbreaking discovery on stem cell regulation
5. Scripps Florida scientists awarded $3 million to develop new, more effective pain treatments
6. Scientists learn how insects remodel their bodies between life stages
7. UF scientists name new ancient camels from Panama Canal excavation
8. MU scientists study how to improve pesticide efficiency
9. Southern insect scientists to meet in Little Rock
10. Emerge attracts futurists to collaborate with scientists, designers artists is redesign of future
11. Geological Society of America member scientists, students, and colleagues meet in Texas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/22/2016)... , PROVO and ... Newborn Screening Ontario (NSO), which operates the highest sample ... molecular testing, and Tute Genomics and UNIConnect, leaders in ... respectively, today announced the launch of a project to ... (NGS) testing panel. NSO has been ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... DIEGO , June 27, 2016  Sequenom, Inc. ... committed to enabling healthier lives through the development of ... Court of the United States ... courts that the claims of Sequenom,s U.S. Patent No. ... patent eligibility criteria established by the Supreme Court,s Mayo ...
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf K. Hoffmann, ... faculty of the University of North Carolina Kenan-Flagler Business School effective ... at UNC Kenan-Flagler, with a focus on the school’s international efforts, leading classes ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... ... June 23, 2016 , ... UAS ... the launch of their brand, UP4™ Probiotics, into Target stores nationwide. The company, ... proud to add Target to its list of well-respected retailers. This list includes ...
Breaking Biology Technology: